Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/19971
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAmarasena, H. L. P.-
dc.contributor.authorSilva, F. H. D. S.-
dc.contributor.authorTilakaratna, P. M. Y. I.-
dc.contributor.authorJayamanne, S. F.-
dc.contributor.authorRanawaka, U. K.-
dc.date.accessioned2019-02-21T06:52:29Z-
dc.date.available2019-02-21T06:52:29Z-
dc.date.issued2019-
dc.identifier.citationBMC infectious diseases.2019; 19(1):143en_US
dc.identifier.issn1471-2334 (Electronic)-
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/19971-
dc.descriptionIndexed in MEDLINEen_US
dc.description.abstractBACKGROUND:Melioidosis is an infection caused by Burkholderia pseudomallei, which is more prevalent in the tropics and leads to significant morbidity and mortality. It characteristically produces widespread caseous lesions and abscesses, and can present with varied clinical manifestations. Melioidosis involving the central nervous system is uncommon. CASE PRESENTATION: A 42-year-old Sri Lankan male with type 2 diabetes presented with a febrile illness of 6 days with headache and constitutional symptoms. Clinical examination was unremarkable. Four days later, he developed focal seizures involving the left leg and numbness of the left side. Initial laboratory investigations were suggestive of a bacterial infection. Blood culture was reported as positive for a Pseudomonas species, which was resistant to gentamicin. Contrast enhanced CT and MRI scans of the brain showed a subdural collection in the right fronto-temporo-parietal region with possible abscess formation. Melioidosis antibody testing using indirect hemagglutination method was reactive with a titre more than 1/10,240. He was treated with intravenous meropenem and oral co-trimoxazole for 8 weeks (Intensive phase). The subdural collection was managed conservatively, and seizures were treated with oral antiepileptics. At 7 weeks, follow-up contrast enhanced MRI showed improvement of the subdural collection, and inflammatory markers had normalized. He was discharged after 8 weeks, and treated with oral co-trimoxazole and doxycycline for 6 months (eradication phase). At 6 months follow-up, the patient is asymptomatic. CONCLUSIONS: Cerebral melioidosis is an unusual presentation of melioidosis where the diagnosis can be easily missed. Knowledge of the protean manifestations of melioidosis is of paramount importance in order to detect and treat this potentially fatal infection appropriately, especially in tropical countries where the disease is endemic.en_US
dc.language.isoenen_US
dc.publisherBioMed Central,Londonen_US
dc.subjectMelioidosisen_US
dc.titleMelioidosis with a subdural collection - a case report.en_US
dc.typeArticleen_US
Appears in Collections:Journal/Magazine Articles

Files in This Item:
File Description SizeFormat 
Melioidosis.pdf7.97 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.